Страна: Армения
Язык: английский
Источник: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում
diclofenac (diclofenac diethylamine)
GlaxoSmithKline Consumer Healthcare S.A.
M02AA15
diclofenac (diclofenac diethylamine)
10mg/g
gel for external use
20g, 50g and 100g laminated tube
OTC
Registered
2019-01-09
GSK Consumer Healthcare S.A., Switzerland. Summary of Product Characteristics Global Labeling VOLTAREN Gel Diclofenac diethylamine 1.16% SUMMARY OF PRODUCT CHARACTERISTICS Document status: FINAL Release date: 10 Oct 2019 Number of pages: 8 GSK Consumer Healthcare S.A., Switzerland. Summary of Product Characteristics TABLE OF CONTENTS 1 NAME OF THE MEDICINAL PRODUCT ....................................................................... 3 2 QUALITATIVE AND QUANTITATIVE COMPOSITION ............................................. 3 3 PHARMACEUTICAL FORM ............................................................................................ 3 4 CLINICAL PARTICULARS .............................................................................................. 3 4.1 Pharmacotherapeutic group ..................................................................................... 3 4.2 Posology and method of administration .................................................................. 4 4.3 Contraindications ..................................................................................................... 4 4.4 Special warnings and precautions for use ................................................................ 5 4.5 Interaction with other medicinal products and other forms of interaction .............. 5 4.6 Pregnancy and lactation ........................................................................................... 5 4.7 Effects on ability to drive and use machines ........................................................... 5 4.8 Undesirable effects .................................................................................................. 6 4.9 Overdose .................................................................................................................. 7 PHARMACOLOGICAL PROPERTIES ................................................................................... 7 4.3 Pharmacodynamic properties ................................................................................... 7 Прочитать полный документ